As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

Many people who have struggled with their weight have been told to “eat less and move more.” Others have spent years juggling ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, subcutaneous formulation, offers the potential for at-home administration, ...

Report Ocean is delighted to unveil an exhaustive analysis of the Philippines Diabetes Drugs Market, presenting a detailed exploration of its various dimensions from 2018 to 2032. Our in-depth study ...